Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Angel Fowler Taylor"'
Autor:
Agnes Annette Schubert-Tennigkeit, Gary T. Ferguson, Angel Fowler Taylor, Qian Wang, Donald Banerji, Chau Thach, Francesco Patalano
Background: The objective of the FLIGHT3 study was to evaluate the long-term safety and efficacy of indacaterol/glycopyrrolate* (IND/GLY) versus an active comparator, IND, in patients with moderate-to-severe chronic obstructive pulmonary disease (COP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d521281073245f782a1234dbf7d9679c
https://europepmc.org/articles/PMC5556955/
https://europepmc.org/articles/PMC5556955/
Autor:
Bob Lanier, I Berhane, Angel Fowler Taylor, Tracy A. Bridges, Marek Kulus, Carlos Fernandez Vidaurre
Publikováno v:
Journal of Allergy and Clinical Immunology. 124:1210-1216
Many children with asthma continue to experience symptoms despite available therapies.This study evaluated the efficacy and safety of omalizumab, a humanized anti-IgE mAb, in children with moderate-to-severe persistent allergic (IgE-mediated) asthma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87c6b3e244c64ddcc56bfe1a8dcc0577
https://doi.org/10.1016/j.jaci.2009.09.021
https://doi.org/10.1016/j.jaci.2009.09.021
Autor:
Donald Banerji, Joachim H. Ficker, Dennis E. Niewoehner, Hungta Chen, Thomas Sandström, Christie Arrasate, Angel Fowler Taylor, Marc Decramer, Jadwiga A. Wedzicha, Peter D'Andrea
Publikováno v:
The Lancet. Respiratory medicine. 1(3)
Summary Background We evaluated the effect of dual, longacting inhaled bronchodilator treatment on exacerbations in patients with severe and very severe chronic obstructive pulmonary disease (COPD). Methods In this parallel-group study, 2224 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80f3f2c95972de19f43c2570adfc39cc
https://pubmed.ncbi.nlm.nih.gov/24429211
https://pubmed.ncbi.nlm.nih.gov/24429211
Autor:
Anjuli, Nayak, Thomas, Casale, S David, Miller, John, Condemi, Margaret, McAlary, Angel, Fowler-Taylor, Giovanni, Della Cioppa, Niroo, Gupta
Publikováno v:
Allergy and asthma proceedings. 24(5)
Two randomized, placebo-controlled, double-blind studies have shown clinical benefit with omalizumab (Xolair), a recombinant humanized monoclonal anti-immunoglobulin E (IgE) antibody, at a dose of 300 mg every 3 or 4 weeks in patients with seasonal a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2030dbc98f279d188abdb438d0b76690
https://pubmed.ncbi.nlm.nih.gov/14619332
https://pubmed.ncbi.nlm.nih.gov/14619332
Autor:
William E. Berger, Stephen Pollard, Margaret McAlary, Henry Milgrom, Angel Fowler Taylor, Niroo Gupta, Anjuli Nayak, Patricia Rohane
Publikováno v:
Pediatrics. 108(2)
Background and Objective.There seems to be a strong causal relationship between allergy and the origins of asthma. Susceptibility to both is determined by a combination of genetics and environment acting through a complex network of cytokines. Nearly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6bf07113d5cf9c493f674fffa6cfb3d
https://pubmed.ncbi.nlm.nih.gov/11829557
https://pubmed.ncbi.nlm.nih.gov/11829557
Autor:
Hungta Chen, Donald Banerji, Thomas Sandström, Angel Fowler Taylor, Marc Decramer, Christie Arrasate, Joachim H. Ficker, Jadwiga A. Wedzicha, Peter D'Andrea, Dennis E. Niewoehner
Publikováno v:
The Lancet Respiratory Medicine. 1:e23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::956e4b47a816ae57d59fc742469beeec
https://doi.org/10.1016/s2213-2600(13)70104-8
https://doi.org/10.1016/s2213-2600(13)70104-8